Role of an Intestinal Rehabilitation Program in the Treatment of Advanced Intestinal Failure

Department of Pediatrics, University of Nebraska Medical Center, Omaha, USA.
Journal of pediatric gastroenterology and nutrition (Impact Factor: 2.63). 09/2007; 45(2):204-12. DOI: 10.1097/MPG.0b013e31805905f9
Source: PubMed


To analyze outcomes in children with intestinal failure treated by our Intestinal Rehabilitation Program (IRP) in a 4-year period.
A total of 51 parenteral nutrition (PN)-dependent patients (20 male) were enrolled in the IRP. Median age was 1.7 years, with the primary diagnoses being gastroschisis, necrotizing enterocolitis, volvulus, and congenital atresia. Median small bowel intestinal length was 35 cm, with the majority of patients having only jejunum as remaining bowel anatomy. Thirty-six of the 51 patients had liver disease characterized by cirrhosis, advance bridging fibrosis, and portal and periportal fibrosis. Height, weight z score, platelet count, albumin, and bilirubin levels were measured at the beginning and end of the study.
Of the 51 patients, 29 had 46 different surgical intestinal repairs. Twenty-nine of the 36 patients with hyperbilirubinemia had normalized serum bilirubin with treatment. Ten patients required transplantation. Five patients died of sepsis, influenza, or complications after intestinal transplantation. Of the remaining 37 patients in the IRP, 31 were weaned from parenteral nutrition (5 with cirrhosis); 6 patients are in the process of weaning. Survival rate of the patients in the IRP was 90%. Growth has continued along the same curve, and some patients have exhibited significant catch-up.
With an aggressive medical/surgical approach, even patients with intestinal failure and advanced liver disease can avoid transplantation. Patients in the IRP showed improved liver function and nutritional parameters with the ability to discontinue PN while maintaining growth. Early referral of these patients to specialized centers before the development of advanced liver disease is recommended.

Download full-text


Available from: Jon Vanderhoof,

  • Lakartidningen 11/1976; 73(42):3546-8.
  • P Crenn ·
    [Show abstract] [Hide abstract]
    ABSTRACT: Intestinal failure is defined as the reduction in the functioning gut mass below the minimal amount necessary for the absorption of nutrients and a normal nutritional status. The main cause of chronic intestinal failure in adults is short bowel syndrome secondary to mesenteric ischemia. In short bowel the remnant bowel length is inferior to 200 cm. The two other causes of intestinal failure are extensive small bowel mucosal diseases and chronic intestinal pseudo-obstruction. The reference treatment of severe chronic intestinal failure is home parenteral nutrition. The main alternate for irreversible intestinal failure is small bowel transplantation, isolated or combined to liver transplantation.
    La Revue du praticien 06/2001; 51(9):977-82.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The modern era of clinical solid organ transplantation has just passed the half-century mark, having closed the 20th century with the long sought clinical success in intestinal transplantation and combinations of abdominal organs (liver-intestine, intestine-pancreas, liver-stomach-pancreas-intestine). Developments in technique, organ preservation, peri-operative care, and immunosuppressive management over the last 15 years have made intestinal transplantation an effective treatment for children with intestinal failure. However, the feasibility of intestinal organ engraftment remained enigmatic, until the demonstration of the interaction of recipient and donor immunocytes (contained in the transplanted organ) and postulated as the two-way paradigm of transplant immunology. This prompted further developments in immunosuppression which has ameliorated the morbidity and mortality that has prevented widespread use of intestinal transplantation. The ripple effects of these advances have resulted in the March 2001 Medicare report which provided a national coverage decision of the Social Security Act for intestinal Transplantation. As of May 2003, there were 61 centers worldwide which had performed 989 intestinal transplants. In this article, we describe the basis for successful clinical intestinal transplantation, reviewing progress with surgical technique, posttransplant management, and the evolution of immunosuppressive drug therapy.
    Seminars in Pediatric Surgery 09/2006; 15(3):228-34. DOI:10.1053/j.sempedsurg.2006.03.010 · 2.22 Impact Factor
Show more